Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

106.22 +2.02 (+1.94%)
Streaming Delayed Price Updated: 9:58 AM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Repligen Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Dow Jones Hits High As Metals, Miners, Fertilizers Thrive, But Growth Stocks Slump; Jobs Report Stunningly Weak ↗
The Dow hit highs but growth stocks slumped, despite a Friday bounce on weak jobs gains. Miners, metals, fertilizers thrived. 
Via Investor's Business Daily
Topics Economy Intellectual Property Stocks
News headline image
Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript ↗
RGEN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Repligen Earnings Double As Sales Growth Accelerates; RGEN Stock Nears Buy Point ↗
Repligen earnings shot up 113% in Q1 with sales growth accelerating to 88%. The biotech raised full-year guidance. RGEN stock rose, nearing a buy point. 
Via Investor's Business Daily
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Repligen: Q1 Earnings Insights ↗
Shares of Repligen (NASDAQ:RGEN) moved higher by 7.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 112.50% over... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7... 
Via Benzinga
News headline image
Repligen Stock Gets Relative Strength Rating Upgrade With Earnings Due ↗
A Relative Strength Rating upgrade for Repligen shows improving technical performance. Will it continue? 
Via Investor's Business Daily
News headline image
Medical Device Maker Quanterix Sees Relative Strength Rating Rise To 86 ↗
On Tuesday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into to 86, up from 80 the day before. 
Via Investor's Business Daily
News headline image
Align Technology Nears Buy Point With Earnings Due ↗
Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around April 28. 
Via Investor's Business Daily
News headline image
Earnings Scheduled For May 4, 2021 ↗
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •... 
Via Benzinga
News headline image
Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark ↗
Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member. 
Via Investor's Business Daily
News headline image
Cancer Therapy Novocure Stock Flashes Renewed Technical Strength ↗
Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92. 
Via Investor's Business Daily
News headline image
10 Biggest Price Target Changes For Monday ↗
Canaccord Genuity raised the price target on Tesla, Inc. (NASDAQ: TSLA) from $419 to $1071. Tesla shares rose 1.5% to $687.13 in pre-market trading. Keybanc lowered the price... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.